Diffuse Hypopigmentation Followed by Hyperpigmentation in an African American Woman with Hemangiopericytoma Treated with Dasatinib

Por Boudadi, Karim, Chugh, Rashmi
Publicado no J Clin Diagn Res (2014)

Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy

Por Davis, Elizabeth J, Chugh, Rashmi
Publicado no Drug Des Devel Ther (2017)

Successful embryo cryopreservation immediately following a full-term delivery in a woman with newly diagnosed Ewing’s sarcoma

Por Giuliani, Emma, Ellman, Erin M., Chugh, Rashmi, Moravek, Molly B.
Publicado no J Assist Reprod Genet (2019)

Gardner's syndrome in a 40-year-old woman: successful treatment of locally aggressive desmoid tumors with cytotoxic chemotherapy

Por Bhama, Prabhat K, Chugh, Rashmi, Baker, Laurence H, Doherty, Gerard M
Publicado em 2006

Stress-induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma

Por Krook, Melanie A., Nicholls, Lauren A., Scannell, Christopher A., Chugh, Rashmi, Thomas, Dafydd G., Lawlor, Elizabeth R.
Publicado em 2014

A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcoma

Por Krook, Melanie A., Hawkins, Allegra G., Patel, Rajiv M., Lucas, David R., Van Noord, Raelene, Chugh, Rashmi, Lawlor, Elizabeth R.
Publicado no Oncotarget (2016)

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

Por Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Publicado no BMC Cancer (2016)

Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcoma

Por Briski, Laurence M, Thomas, Dafydd G, Patel, Rajiv M, Lawlor, Elizabeth R, Chugh, Rashmi, McHugh, Jonathan B, Lucas, David R
Publicado no Rare Tumors (2018)

Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Al...

Por Fox, Elizabeth, Patel, Shreyaskumar, Wathen, J. Kyle, Schuetze, Scott, Chawla, Sant, Harmon, David, Reinke, Denise, Chugh, Rashmi, Benjamin, Robert S., Helman, Lee J.
Publicado em 2012

Primary Cardiac Sarcoma: A Rare, Aggressive Malignancy with a High Propensity for Brain Metastases

Por Siontis, Brittany L., Zhao, Lili, Leja, Monika, McHugh, Jonathan B., Shango, Maryann M., Baker, Laurence H., Schuetze, Scott M., Chugh, Rashmi
Publicado no Sarcoma (2019)

Wnt/β-catenin–activated Ewing sarcoma cells promote the angiogenic switch

Por Hawkins, Allegra G., Pedersen, Elisabeth A., Treichel, Sydney, Temprine, Kelsey, Sperring, Colin, Read, Jay A., Magnuson, Brian, Chugh, Rashmi, Lawlor, Elizabeth R.
Publicado no JCI Insight (2020)

A phase 1 study of the heat shock protein 90 inhibitor retaspimycin hydrochloride (IPI-504) in patients with gastrointestinal stromal tumors or soft tissue sarcomas

Por Wagner, Andrew J., Chugh, Rashmi, Rosen, Lee S., Morgan, Jeffrey A., George, Suzanne, Gordon, Michael, Dunbar, Joi, Normant, Emmanuel, Grayzel, David, Demetri, George D.
Publicado no Clin Cancer Res (2013)

Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors

Por Saraiya, Biren, Chugh, Rashmi, Karantza, Vassiliki, Mehnert, Janice, Moss, Rebecca A., Savkina, Nelli, Stein, Mark N., Baker, Laurence H., Chenevert, Thomas, Poplin, Elizabeth A.
Publicado no Invest New Drugs (2010)

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with...

Por Choy, Edwin, Ballman, Karla, Chen, James, Dickson, Mark A., Chugh, Rashmi, George, Suzanne, Okuno, Scott, Pollock, Raphael, Patel, Rajiv M., Hoering, Antje, Patel, Shreyaskumar
Publicado no Sarcoma (2018)

A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

Por Smith, David C., Chugh, Rashmi, Patnaik, Amita, Papadopoulos, Kyriakos P., Wang, Min, Kapoun, Ann M., Xu, Lu, Dupont, Jakob, Stagg, Robert J., Tolcher, Anthony
Publicado no Invest New Drugs (2018)

Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prio...

Por Choy, Edwin, Ballman, Karla, Chen, James, Dickson, Mark A., Chugh, Rashmi, George, Suzanne, Okuno, Scott, Pollock, Raphael, Patel, Rajiv M., Hoering, Antje, Patel, Shreyaskumar
Publicado no Sarcoma (2019)

Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases

Por Hung, Jennifer, Hiniker, Susan M., Lucas, David R., Griffith, Kent A., McHugh, Jonathan B., Meirovitz, Amichay, Thomas, Dafydd G., Chugh, Rashmi, Herman, Joseph M.
Publicado em 2013

The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework

Por Siegel, Geoffrey W, Biermann, J Sybil, Chugh, Rashmi, Jacobson, Jon A, Lucas, David, Feng, Mary, Chang, Andrew C, Smith, Sean R, Wong, Sandra L, Hasen, Jill
Publicado no J Multidiscip Healthc (2015)

Next generation sequencing of extraskeletal myxoid chondrosarcoma

Por Davis, Elizabeth J., Wu, Yi-Mi, Robinson, Dan, Schuetze, Scott M., Baker, Laurence H., Athanikar, Jyoti, Cao, Xuhong, Kunju, Lakshmi P., Chinnaiyan, Arul M., Chugh, Rashmi
Publicado no Oncotarget (2017)

Safety, pharmacokinetics, and pharmacodynamic properties of oral DEBIO1143 (AT-406) in patients with advanced cancer: results of a first-in-man study

Por Hurwitz, Herbert I., Smith, David C., Pitot, Henry C., Brill, Jeffrey M., Chugh, Rashmi, Rouits, Elisabeth, Rubin, Joseph, Strickler, John, Vuagniaux, Gregoire, Sorensen, J. Mel, Zanna, Claudio
Publicado no Cancer Chemother Pharmacol (2015)